Table 4. Case-control analysis for 30-day mortality between patients with tigecycline-resistant and tigecycline-susceptible carbapenem-resistant Klebsiella pneumoniae infection.
| Variables | Tigecycline-resistant(n = 16) | Tigecycline-susceptible(n = 16) | p value |
|---|---|---|---|
| Age (years), mean ± SD | 64.6 ± 26.0 | 66.3 ± 20.1 | 0.833 |
| Male gender, no. (%) | 9 (56) | 9 (56) | 1.000 |
| Type of infection, no. (%) | 1.000 | ||
| UTI | 10 (63) | 10 (63) | |
| Non-UTI | 6 (38) | 6 (38) | |
| APACHE II score, mean ± SD | 22.8 ± 9.0 | 22.1 ± 11.2 | 0.863 |
| Appropriate antibiotics treatment, no. (%) | 10 (63) | 9 (56) | 1.000 |
| 30-day mortality, no. (%) | 7 (44) | 5 (31) | 0.716 |
APACHE II, Acute Physiology and Chronic Health Evaluation II; SD, standard deviation; UTI, urinary tract infection.